Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC3 | O15379 | 5/20 | 0.36 |
| ▸ | HDAC4 | P56524 | 5/20 | 0.36 |
| ▸ | HDAC1 | Q13547 | 5/20 | 0.36 |
| ▸ | HDAC7 | Q8WUI4 | 5/20 | 0.36 |
| ▸ | HDAC2 | Q92769 | 5/20 | 0.36 |
| ▸ | HDAC10 | Q969S8 | 5/20 | 0.36 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.36 |
| ▸ | HDAC8 | Q9BY41 | 5/20 | 0.36 |
| ▸ | HDAC6 | Q9UBN7 | 5/20 | 0.36 |
| ▸ | HDAC9 | Q9UKV0 | 5/20 | 0.36 |
| ▸ | HDAC5 | Q9UQL6 | 5/20 | 0.36 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.35 |
| ▸ | FDPS | P14324 | 2/20 | 0.33 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.31 |
| ▸ | EGFR | P00533 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL995488 | 0.79 | S1PR3 (0.38) | HDAC6 | |
| SCHEMBL995050 | 0.79 | S1PR3 (0.38) | HDAC6 | |
| SCHEMBL8927408 | 0.72 | TAAR1 (0.35) | — | |
| SCHEMBL995340 | 0.72 | — | — | |
| SCHEMBL8967760 | 0.68 | CTRC (0.31) | — | |
| SCHEMBL14245091 | 0.68 | HTT (0.49) | ALOX5FDPSGGPS1TDP1 | |
| SCHEMBL995491 | 0.66 | NOS3 (0.31) | — | |
| SCHEMBL27434096 | 0.65 | HTT (0.44) | ALOX5FDPSGGPS1TDP1 | |
| SCHEMBL11759067 | 0.65 | HPGD (0.51) | TDP1 | |
| SCHEMBL19549554 | 0.65 | ALOX5 (0.43) | ALOX5FDPSGGPS1EGFRTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9133211-B2 | Dithienobenzodithiophene semiconductive material and electronic device using the same | RICOH COMPANY, LTD. (JP) | 2015-09-15 | — | — | US | disclosed |
| EP-2457272-A1 | NOVEL ORGANIC SEMICONDUCTIVE MATERIAL AND ELECTRONIC DEVICE USING THE SAME | Ricoh Company, Ltd. (JP) | 2012-05-30 | — | — | EP | disclosed |
| US-20120119195-A1 | NOVEL ORGANIC SEMICONDUCTIVE MATERIAL AND ELECTRONIC DEVICE USING THE SAME | RICOH COMPANY, LTD. (JP) | 2012-05-17 | — | — | US | disclosed |
| WO-2011010710-A1 | NOVEL ORGANIC SEMICONDUCTIVE MATERIAL AND ELECTRONIC DEVICE USING THE SAME | RICOH COMPANY, LTD. (JP) | 2011-01-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120119195-A1 | NOVEL ORGANIC SEMICONDUCTIVE MATERIAL AND ELECTRONIC DEVICE USING THE SAME | RPS10, OR10J3, RPS20 | HDAC3 4311/4885HDAC4 4564/4885HDAC1 2352/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.